Source: Dermatology Times Gender gaps, with consistent underrepresentation of females, present a substantial challenge in clinical research.(1) Achieving a balanced representation of both genders has
Source: Pharmacy Times Gender gaps, with consistent underrepresentation of females, present a substantial challenge in clinical research.1 Achieving a balanced representation of both genders has
Source: PRWeb The cost of patients dropping out of clinical trials continues to be a major problem for the development of new drugs and treatments
Source: Cision PRweb The FDA has released new guidance for decentralized clinical trials (DCTs) for drugs, biological products, and medical devices to improve DCT implementation.
Clinical trials are the long and complex process by which biopharmaceutical companies must prove the safety and efficacy of investigational new therapies to FDA before
Wed, October 26, 2022 at 5:35 PM-6 min read Clinical trials rely on volunteer populations that can be challenging to access and monitor. Inadequate diversity
Information technology, underpinned by advancements in Cloud computing, is no longer the understudy to the scientific, R&D lead. Biotech, pharma, healthcare and medtech organizations need
Clinical trials are expensive, take significant time, and can run into any number of challenges and delays. The average drug study will see a 30%
Source: PubsOnline Over the past two years, the testing of new medical devices, drugs and vaccines has increasingly been performed outside large medical centers. Faster
Maximizing Clinical Trial Access, Diversity, and Efficiency are Keys to Optimizing Orphan Drug Development February 22, 2022 February is Rare Disease Month—an important time when
